Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Ann Knoop

A time and motion study of subcutaneous versus intravenous trastuzumab in patients with HER2-positive early breast cancer

scientific article published on 25 January 2016

Aberrations of ERBB2 and TOP2A genes in breast cancer.

scientific article

Alterations in circulating miRNA levels following early-stage estrogen receptor-positive breast cancer resection in post-menopausal women.

scientific article

CEF is superior to CMF for tumours with TOP2A aberrations: a Subpopulation Treatment Effect Pattern Plot (STEPP) analysis on Danish Breast Cancer Cooperative Group Study 89D.

scientific article published on 13 May 2010

Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis

scientific article published on March 2015

Correlation between circulating cell-free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA-mutated metastatic breast cancer.

scientific article published on 4 May 2018

Correlation between molecular genetic analyses and immunohistochemical evaluation of the epidermal growth factor receptor and p185HER2

scientific article published on July 1, 1998

Costs of subcutaneous and intravenous administration of trastuzumab for patients with HER2-positive breast cancer

scientific article published on 4 December 2017

Detecting Plasma Tumor DNA in Early-Stage Breast Cancer--Letter

scientific article published on 01 August 2015

Docetaxel-induced neuropathy: A pharmacogenetic case-control study of 150 women with early-stage breast cancer

scientific article published on 10 November 2014

ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer ⬇️

scientific article published on June 11, 2011

Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration.

scientific article published on 5 December 2017

Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients

scientific article published on 19 November 2015

Gene expression signatures that predict outcome of tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG study

scientific article

Genomic Analyses of Breast Cancer Progression Reveal Distinct Routes of Metastasis Emergence.

scientific article

High Concordance Between Two Companion Diagnostics Tests

scientific article published on 01 July 2011

Identification of metastasis driver genes by massive parallel sequencing of successive steps of breast cancer progression

scientific article published on 2 January 2018

Immunohistochemical assessment of oestrogen and progesterone receptors: correlations with the DCC method and clinical outcome in primary breast cancer patients

scientific article published on 01 August 2000

Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients

scientific article published on January 2003

Intratumor genetic heterogeneity of breast carcinomas as determined by fine needle aspiration and TaqMan low density array.

scientific article

Lack of association between level of Plasminogen Activator Inhibitor-1 and estimates of tumor angiogenesis in early breast cancer

article

Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A status ⬇️

scientific article published on November 26, 2011

Low risk of recurrence in breast cancer with negative sentinel node

scientific article published on April 1, 2011

Molecular subtyping of breast cancer improves identification of both high and low risk patients.

scientific article published on 22 November 2017

Neoadjuvant letrozole for postmenopausal estrogen receptor-positive, HER2-negative breast cancer patients, a study from the Danish Breast Cancer Cooperative Group (DBCG).

scientific article published on 23 November 2017

Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.

scientific article

PIK3CA Mutations May Be Discordant between Primary and Corresponding Metastatic Disease in Breast Cancer ⬇️

scientific article published on October 12, 2010

PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab.

scientific article published on 15 December 2011

Palliative treatment with carboplatin as late line therapy to patients with metastatic breast cancer

scientific article published on 5 December 2017

Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study

scientific article published on 28 July 2014

Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors

scientific article published on 22 December 2014

Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study

Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study

scientific article published on 19 August 2013

Prognostic and predictive factors for endocrine treatment in breast carcinoma

scientific article published in September 2007

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.

scientific article

Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer

scientific article published on 17 October 2013

Switching between intravenous and subcutaneous trastuzumab: Safety results from the PrefHer trial.

scientific article

TAXTOX - a retrospective study regarding the side effects of docetaxel given as part of the adjuvant treatment to patients with primary breast cancer in Denmark from 2007 to 2009.

scientific article published on 9 August 2011

The prognostic relevance of estimates of proliferative activity in early breast cancer.

scientific article

The value of TOP2A gene copy number variation as a biomarker in breast cancer: Update of DBCG trial 89D.

scientific article published on January 2008

YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer.

scientific article published on 22 December 2007

[Use of complementary and alternative medicine (CAM) in breast cancer patients. Efficacy and interactions]

scientific article published on 01 September 2007

Paulina is supported by:

About Paulina

Help